BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 9 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 9 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 9 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 12 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 12 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

General Dynamics stock up on Q1 earnings beat

General Dynamics (GD) kicked-off fiscal 2019 in style by reporting solid headlines numbers which surpassed analyst estimates. However, increased expenses dragged profits by 6.8%. The…

Market News

Spinraza helps Biogen beat the street in Q1

A month after announcing the withdrawal from its Phase 3 Alzheimer’s trials, biopharma firm Biogen (NASDAQ: BIIB) on Wednesday reported first-quarter earnings that surpassed Wall…